Prostate cancer describes the development of cancer in the prostate. The prostate is a gland in the male reproductive system. The disease normally develops slowly, with symptoms emerging sometime ...

Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos ...

Scientists used CRISPR to make prostate cancer cells easier for the immune system to detect and destroy. The experimental ...

New research has shown that immunotherapy can be effective in treating prostate cancer in men who are selected based on the genetic characteristics of their tumors. In a recent study, it was found ...

Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president’s prostate cancer is characterized ...

When a cancer cell leaves the original tumor to spread to a new, faraway location, it first has to survive what most cells ...

If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.

Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is a medicine that is used to treat certain types of prostate cancer. Pluvicto may be used to treat PSMA-positive prostate cancer that has spread to ...